Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients.
D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008607:Intellectual Disability / Q000150:complications*; D008274:Magnesium / Q000097:blood; D008297:Male; D008618:Mephobarbital / Q000627:therapeutic use; D008653:Mesoridazine / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D010758:Phosphorus / Q000097:blood; D011188:Potassium / Q000097:blood; D011324:Primidone / Q000627:therapeutic use; D012279:Rickets / Q000209:etiology*; D012640:Seizures / Q000188:drug therapy*; D012964:Sodium / Q000097:blood; D013388:Succinimides / Q000627:therapeutic use; D014807:Vitamin D
D000927:Anticonvulsants; D013388:Succinimides; D011324:Primidone; D014807:Vitamin D; D010758:Phosphorus; D008618:Mephobarbital; D008653:Mesoridazine; D010672:Phenytoin; D012964:Sodium; D000469:Alkaline Phosphatase; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D010634:Phenobarbital